SCHEDULE: BlackRock Amends Passive Stake in Cabaletta Bio, Inc.
Beneficial Ownership Disclosure
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a 1.0% beneficial ownership stake in Cabaletta Bio, Inc. as of June 30, 2025.
Summary
- BlackRock, Inc. reported beneficial ownership of 894,647 shares of Cabaletta Bio, Inc. common stock.
- This ownership represents 1.0% of the total outstanding common stock of Cabaletta Bio, Inc.
- BlackRock holds sole voting power over 892,668 shares and sole dispositive power over 894,647 shares.
- The filing is an Amendment No. 2 to a Schedule 13G, indicating an update to previously reported ownership.
- BlackRock certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Cabaletta Bio, Inc.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing disclosing passive ownership, providing no direct positive or negative operational or financial information about the issuer. The sentiment is neutral as it simply reports a factual ownership stake.
Future Outlook
NA
Industry Context
This filing is a routine disclosure by a major institutional investor, BlackRock, indicating its passive ownership stake in Cabaletta Bio, Inc. Such Schedule 13G filings provide transparency on significant shareholdings by institutional investors who do not intend to influence or control the issuer, which can be relevant for understanding institutional interest and liquidity in a company's stock.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder's stake, which can influence market perception and liquidity.
Key Dates
| Date | Description |
|---|---|
| 04/30/2023 | Previous Power of Attorney revoked by BlackRock, Inc. |
| 01/21/2025 | New Power of Attorney executed by BlackRock, Inc. |
| 06/30/2025 | Date of event which requires filing of this statement for BlackRock's ownership in Cabaletta Bio, Inc. |
| 07/16/2025 | Date of signature for the Schedule 13G Amendment No. 2 filing by BlackRock, Inc. |
Keywords
BlackRock, Cabaletta Bio, SEC filing, Schedule 13G, beneficial ownership, institutional investment, common stock, passive investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.